The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Avandia drug manufacturer, GlaxoSmithKline, failed to disclose several studies about Avandia to the FDA. Earlier this year, the FDA issued a warning letter to GlaxoSmithKline for postmarketing safety reporting failures. This letter can be viewed at GlaxoSmithKline suggested that any omission of data was inadvertant and not intentional. In order to prevent this from happening again, GlaxoSmithKline intends to provide additional training to its employees on reporting requirements. For some injured by this drug, this may be too little too late. In November 2007, FDA officials required a black box warning that the medicine may increase the risk of heart attack. If you or a loved one has been injured by this product, you should speak with an attorney to evaluate your case.

Comments are closed.

Of Interest